RUTHFULLY YOURS

https://www.frontpagemag.com/fpm/272833/brutal-murder-jewish-teen-ari-lieberman

When police and security forces discovered 19-year-old Ori Ansbacher in Jerusalem’s Ein Yael forest on Friday, she was already dead. Police noted that she was murdered in a brutal fashion having been stabbed at least 12 times in the chest and neck. There were other signs of brutality but in deference to police requests and the dignity of the Ansbacher family, I will refrain from noting them here. Needless to say, this was a barbaric crime even by Palestinian standards of barbarity.

Forensic teams scoured the site for evidence and within 24 hours, there was a significant evidentiary breakthrough that led to the doorstep of 29-year-old Hebron resident, Arafat Irfayia. So strong was the physical evidence that police noted that they could secure a conviction even without a confession. Following the crime, Irfayia hid in a mosque in the Arab village of El-Bireh, and subsequently made his way to a home adjacent to the mosque where Israeli security forces nabbed him. His Hebron home has already been mapped for demolition.

On Sunday, Irfayia reenacted the crime for investigators. On day of the murder, Irfayia, who was known to law enforcement, left his Hebron home armed with a knife and made his way to Jerusalem, where he stumbled upon his innocent female victim. It was a crime of opportunity and unfortunately, Ori became a victim of Irfayia’s monstrous hate of Jews and deviant sexual proclivities.

www.verygoodnewsisrael.blogspot.com

In this week’s newsletter, Israel is the country of choice for Microsoft, Cisco, Samsung, Centrica, Toyota, Brose, the European Space Agency, the British Museum, the American Red Cross, Japan, Finland, Chile, 250 Ukranians, 83 Ethiopians, the United Nations’ NGO Committee, Jamie Oliver and a record 285,000 January tourists.

ISRAEL’S MEDICAL ACHIEVEMENTS

Immune response to donor cells can kill cancer. Israeli biotech Immunovative Therapies purifies and cultures healthy T-cells from an unmatched donor. The cells (called AlloStim) are injected into the cancer patient and after several treatments, boosts the recipient’s immune system to kill the tumors. Phase 2/3 trials in progress.
https://www.israel21c.org/could-an-immunotherapy-treatment-from-israel-cure-cancer/
https://clinicaltrials.gov/ct2/show/NCT01741038?term=allostim&draw=2&rank=2

Shutting down cancer resistance. Israeli biotech Kitov has proved its NT219 anti-cancer treatment triggers irreversible shutdown of tumor survival pathways in multiple cancers. In a separate announcement, US biotech Coeptis will distribute Consensi – Kitov’s dual osteoarthritis pain and hypertension treatment in the US.
http://kitovpharma.investorroom.com/news-releases?item=72
http://kitovpharma.investorroom.com/news-releases?item=73

New molecules have “wonder” potential. Hebrew University of Jerusalem scientists have discovered 27 new molecules that could treat fatty liver disease, obesity, diabetic nephrotoxicity, and to heal wounds. They devised an algorithm to search a database of 1.56 million molecules for those with therapeutic potential.
https://new.huji.ac.il/en/article/37855

Digital stethoscope goes global. I reported previously (see here) on Israel’s TytoCare and its digital stethoscope that diagnoses a patient and sends the data electronically to a remote physician. TytoCare has now received European and Canadian approval to match its US approval and plans to expand in Europe and Asia.
https://www.calcalistech.com/ctech/articles/0,7340,L-3754450,00.html

Non-verbal communication. When hospital patients cannot communicate with their relatives, it can be very distressing for both. Which is why Israeli NGO Ezer Mizion the “Handbook for the Hospitalized Patient.” It is built as a flowchart – the patient then answers “yes” and “no” questions to communicate successfully.
http://www.ezermizion.org/blog/playing-twenty-questions-in-the-hospital-room/

https://www.jpost.com/Opinion/Right-from-wrong-Is-Gantz-

When the new Great White Hope of the Israeli opposition, Benny Gantz, delivered his first public speech last week, the press couldn’t contain its excitement. During the hours before he took to the podium to address a packed hall of supporters, all Hebrew broadcasters treated the event as momentous enough to warrant an hour-by-hour countdown.

The fervor was palpable. Prior to Gantz’s December 27 announcement of the formation of his party, Israel Resilience, the Left was on the verge of despair. Polls were showing the implosion of the once illustrious Labor Party – whose past prime ministers include David Ben-Gurion, Golda Meir, Yitzhak Rabin and Shimon Peres – and the fizzling out of the elusive “center.”

Prime Minister Benjamin Netanyahu’s Likud Party, on the other hand, was soaring in the surveys. Consensus had it that Likud would emerge victorious in the April 9 elections. To prevent the sure win from being too great – and to force Netanyahu to forge a coalition with others vying for prized portfolios – parties across the spectrum went into high gear, if not high anxiety.

When Gantz threw his hat into the ring, the mood instantly shifted. Here was a guy who might give Netanyahu a run for his money. At 59, the former IDF chief of staff is neither too young nor too old. He is also tall and handsome, with piercing blue eyes that, until four years ago, gloriously contrasted his dark green military uniform.

https://www.jns.org/opinion/primary-concerns/

(February 5, 2019 / JNS) It’s not a hot news flash that Israeli Prime Minister Benjamin Netanyahu is the nemesis of the local left-wing media. Nor is it novel that the feeling is mutual. But ahead of Tuesday’s primaries in Likud, the party Netanyahu chairs, an amusing twist was added to the mix.

Unlike the vast majority of Israeli parties, Likud determines its Knesset list democratically through internal elections in which all dues-paying members are eligible to vote. This means that Netanyahu needs to campaign for the candidates of his choice, rather than simply appointing them at will, the way other party leaders do. Naturally, he has loyalists and rivals within his party. Obviously, he favors the former.

No scandal there. Unless, of course, you’re an Israeli journalist who needs to create one as part of your proverbial putsch attempt.

Whatever else can be said of Netanyahu, he is no dummy, as even his enemies acknowledge. To circumvent the incessant negative coverage aimed at ousting him through ludicrous criminal charges—ironically involving moves on his part to be given a fair shake by the press—Netanyahu launched an Internet channel, Likud TV, for the purpose of broadcasting his message and garnering public support ahead of the April 9 elections. To mock the endeavor, the Israeli media called it a “copycat” version of U.S. President Donald Trump’s weekly “Real News Update.”

http://www.israelhayom.com/2019/02/04/israel-releases-

Several dozen current or former members of Hamas and the PFLP are involved in BDS activity through Palestinian and international NGOs, Strategic Affairs Ministry report says • “What we discovered surprised even us,” says Strategic Affairs Minister Gilad Erdan.

The government released a report Sunday claiming to reveal close links between the Palestinian-led boycott movement against Israel and terrorist groups.

The Strategic Affairs Ministry, which leads Israel’s efforts against the boycott, divestment and sanctions movement, said it uncovered extensive connections between pro-boycott groups and activists affiliated with Hamas and the Popular Front for the Liberation of Palestine.

The BDS movement dismissed the report as “wildly fabricated.”

The 80-page report claims several dozen current or former members of the Palestinian groups, both designated terrorist organizations by the U.S., European Union and Israel, are involved in BDS activity through Palestinian and international nongovernmental organizations.

“We have always seen indications of connections between BDS groups and designated terrorist organizations,” Strategic Affairs Minister Gilad Erdan said. “What we discovered surprised even us.”

Most of the cases were based on accusations of affiliation or expressions of sympathy for terrorist groups, in some instances connected to acts that took place years ago. At least two people on the list have received international recognition for human rights work.

https://besacenter.org/perspectives-papers/israel-red-lines-lebanon-syria/

Israel’s low-profile military campaign against the Iranian-Shiite axis in Syria is continuing despite changes in the geo-strategic environment. But the use of Israeli air power to disrupt enemy force build-up has yet to cross into Lebanon. It is possible that this could represent one of the most significant regional escalation scenarios in the near future.

The “War Between Wars” is an ongoing Israeli military and intelligence effort to disrupt the force build-up of the Iranian-Shiite axis throughout the Middle East. This campaign, which has evolved into an entire force activation doctrine, has seen the Israeli defense establishment employ an approach that differentiates between Syria and Lebanon.

In Syria, Israel launches frequent intelligence-fueled air strikes that target Iranian military build-up sites. The strikes also destroy Iranian weapon transfers that use Syria as a transit zone on their way to Hezbollah bases in Lebanon.

The scope of Israel’s preventative air strike campaign in Syria is enormous, as recently outlined by former IDF Chief of Staff Lt.-Gen. Gadi Eisenkot. Eisenkot told the New York Times that Israeli jets had fired 2,000 air-to-ground munitions at targets in Syria in 2018 alone.

This has clearly disrupted Iran’s plans to build a Shiite army in Syria under its command, made up of 100,000 militia members. Iran was also planning to build missile factories, launch sites, weapons storage facilities, and a network of cross-border attack positions along Syria’s border with Israel.

All these advances in technology, science and medicine are available to all Israel’s population- Christian, Moslem, Jews, Arabs, Africans…giving the lie to the spurious and venal claims of the myriad pseudo human rights organizations that routinely slander Israel. rsk

www.verygoodnewsisrael.blogspot.com

ISRAEL’S MEDICAL ACHIEVEMENTS

Multiple attack on cancer. Israel’s Accelerated Evolution Biotechnologies (AEBi) is developing an anti-cancer technology that identifies multiple peptides (small proteins) for targeting specific cancer cells and any mutations. Each treatment will also include a toxin to suppress the cancer’s ability to deactivate the treatment.
https://www.jpost.com/HEALTH-SCIENCE/A-cure-for-cancer-Israeli-scientists-say-they-think-they-found-one-578939 http://www.aebi-bio.com/

Using antibodies to treat damaged cells. I’ve reported previously (see here)on Israeli medical innovations to boost the immune system to fight diseases. Israeli biotech Biond Biologics is developing a platform to enable antibodies to enter cells, destroy tumors or treat autoimmune diseases. Biond just raised $17 million of funds.
http://www.biondbio.com/platform/ https://www.calcalistech.com/ctech/articles/0,7340,L-3753832,00.html

Using yeast to find cures for metabolic disorders. Tel Aviv University researchers have uncovered a new pathway that can speed up the search for cures for hundreds of metabolic disorders that are fatal to infants. They have modified yeast cells to generate a toxic build-up of metabolites in the lab, for testing possible therapies.
https://www.jewishpress.com/news/science-and-tech/new-israeli-research-may-lead-to-life-saving-therapies-for-metabolic-disorders/2019/01/17/

US approval for bio bone-fixing pins. (TY OurCrowd) The US FDA has granted clearance to Israel’s Ossio for its OSSIOfiber family of bio-integrative bone pins, which secure broken bones during the healing process while leaving no permanent hardware behind. https://www.youtube.com/watch?v=QhiHflP1nGE
https://www.fiercebiotech.com/medtech/fda-clears-ossio-s-integrative-mineral-bone-pins-for-orthopedic-surgeries https://ossio.io/

Pfizer partners with Israeli AI biotech. (TY Calcalistech) I reported previously (16th Dec) on Israel’s CytoReason which uses an Artificial Intelligent learning model to discover treatments related to the human immune system. CytoReason has just partnered with Pfizer – its fifth alliance with a major company.
http://nocamels.com/2019/01/drug-discovery-cytoreason-pfizer/
https://docs.wixstatic.com/ugd/216dd2_5d94d4baffe5460d80e3fcbe79c5c1ea.pdf

Partners to prevent dementia. The innovation arm of Israel’s Sheba Medical Center has partnered with Japanese telecom manufacturer OKI Electric Industry to set up a new joint research project that will focus on the prevention of dementia in high-risk middle-aged individuals.
https://www.timesofisrael.com/sheba-medical-center-japans-oki-electric-join-forces-against-dementia/

How to measure pain. Israelis Yariv Adan and Ariel Assaf are the co-founders of Lab 39, developer of the Genie pain tracker. It comprises a wristband with sensors that track sleep patterns, physical activity and heart rate. Its partner is a smartphone app which requests the patient to enter a pain score several times a day.
https://www.timesofisrael.com/to-measure-and-track-pain-israeli-duo-develops-objective-monitor/

Israeli medic saves life in Mecca. Refai Amer, a Muslim Israeli-Arab from Kfar Qassim is a volunteer medic for Israel’s United Hatzalah. He recently went to Mecca for the Haj, taking his medkit with him. In the middle of prayers, surrounded by around 7 million worshippers, he saved the life a man suffering from a hypoglycemia.
https://unitedwithisrael.org/watch-meet-the-israeli-medic-who-saved-a-life-in-mecca/
https://www.youtube.com/watch?v=w15eMWSeYmY